News and Updates

  • Press release
  • News
9 Jul 2019

Coloplast completes its SenSura® Mio ostomy care range with new innovative products for premature babies and kids

Coloplast proudly presents two new members of the SenSura® Mio family, SenSura® Mio Baby and SenSura® Mio Kids. The new products are designed specifically for premature babies and kids. As part of the launch, Coloplast is also publishing best practice guidelines created by stoma care nurses with solid experience treating babies and kids living with a stoma.

Read more

Our bodies are different, and it is a challenge to create products to fit individual bodies. This is also the case when it comes to premature babies and kids. That is why Coloplast is proud to present two additional and customised SenSura® Mio ostomy care products, SenSura® Mio Baby and SenSura® Mio Kids. Coloplast now offers a full range of ostomy care products to fit everyone and every body profile.


While SenSura® Mio, SenSura® Mio Convex, and SenSura® Mio Concave are designed to fit the individual shapes of adults with regular, inward, and outward body profiles, SenSura® Mio Baby and SenSura® Mio Kids are designed and developed especially for babies and kids.

 

“While it is uncommon for babies and kids to undergo stoma surgery, we want to make sure those who do have the best possible products. Despite it being difficult to create a great fit for the littlest of users, our latest products do just that,” says CEO Kristian Villumsen, Coloplast.

 

"As a market leader, we are proud to offer innovative products like SenSura® Mio Baby and SenSura® Mio Kids, which helps these little ostomates live healthy lives and not be limited by their conditions,” says Mr. Villumsen.

 

New best practice guidelines by stoma care professionals

The SenSura® Mio Baby products aim to provide longer wear time, as especially premature babies have sensitive skin, which needs as much peace and quiet as possible.

 

The new products include a best practice guideline developed by pediatric stoma care nurses with solid experience with babies and kids living with a stoma.

 

Red Dot award winner

Both SenSura® Mio Baby and SenSura® Mio Kids have won the Red Dot Award: Product Design 2019. The 'Red Dot' is the award for high quality design, and the international jury grants this seal of quality to products that feature an innovative and outstanding design.

 

“With the star-shaped baseplate, SenSura® Mio Kids is designed specifically for children’s round bellies. It is exciting to see the innovative SenSura® Mio Baby and SenSura® Mio Kids products being recognised for its design. I believe that these products successfully combine functionality and design – this is design with a purpose,” says SVP of Global Marketing Rasmus Hannemann, Coloplast.

 

Learn more on: www.red-dot.org

 

 

  • SenSura® Mio Baby and SenSura® Mio Kids will be launched in Coloplast’s key markets throughout 2019.
  • Coloplast is the global market leader in ostomy care products, holding 35-40% of the market.
  • Photos of SenSura® Mio Baby and SenSura® Mio Kids are available on https://www.coloplast.com/press/download-images/

 

 

CONTACTS 
Lina Danstrup

Senior Media Relations Manager, Corporate Communications

+45 49 11 26 07

dklina@coloplast.com

 

Ellen Bjurgert

Vice President, Investor Relations

+45 49 11 33 76

dkebj@coloplast.com 


  • Press release
  • News
25 Feb 2019

Coloplast awarded general urological products agreement with Premier Inc.

Minneapolis (February 25, 2019) - Coloplast, a global medical device company and leader in intimate healthcare needs, has been awarded a three-year group purchasing agreement for general urological products with Premier. The new agreement allows Premier members access to Coloplast’s full portfolio of general urological products, including catheters, drainage systems and accessories.

Read more

Coloplast awarded general urological products agreement with Premier Inc.

 

Coloplast, a global medical device company and leader in intimate healthcare needs, has been awarded a three-year group purchasing agreement for general urological products with Premier. The new agreement allows Premier members access to Coloplast’s full portfolio of general urological products, including catheters, drainage systems and accessories.

 

“We are extremely honored that Premier Inc. has chosen to work with Coloplast. Coloplast shares Premier’s core values to improve patient outcomes and provide value to its customers,” said Manu Varma, senior vice president of Chronic Care North America.

 

The agreement is effective for three years beginning March 1, 2019. Premier is a leading healthcare improvement company, uniting an alliance of approximately 4,000 U.S. hospitals and 165,000 other providers to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and advisory and other services, Premier enables better care and outcomes at a lower cost.

 

About Coloplast continence care products

Coloplast’s range of innovative continence care products are created to allow users to better control their bladder management. By working closely with clinical experts and patients who use catheters daily, we have developed award-winning products. This includes SpeediCath®, the world’s first ready-to-use hydrophilic-coated intermittent catheter, and Conveen® Optima, the next generation of male external catheters. These products are designed to improve the quality of life for those in need and are preferred by users.

 

In addition to product solutions, Coloplast has developed Coloplast® Care, a patient support program which provides catheter users access to education and tools for self-assessment and individualized live support from Care Advisors. Coloplast Care provides reliable information so catheter users can better manage their care and experience a full life.

 

About Coloplast

Danish medical device company Coloplast develops products and services designed to make life easier for people with intimate health conditions. Coloplast listens to end-users to better understand their needs and responds by bringing the best ideas to market in the form of medical devices and service solutions. www.coloplast.us/about-coloplast

 

Global press contact

Lina Danstrup, Senior Media Relations Manager

+45 4911 2607

dklina@coloplast.com  

  • Press release
  • News
12 Feb 2019

Coloplast continues to expand its SenSura® Mio ostomy range with the new, innovative, first-of-its-kind SenSura® Mio Convex Flip ostomy product.

Minneapolis (February 12, 2019) - Coloplast, a global medical device company and leader in intimate healthcare needs, continues to expand its SenSura® Mio ostomy range with the new, innovative, first-of-its-kind SenSura® Mio Convex Flip ostomy product.

Read more

Coloplast continues to expand its SenSura® Mio ostomy range with the new, innovative, first-of-its-kind SenSura® Mio Convex Flip ostomy product.

 

Designed specifically for the outward body shapes – and the first of its kind in the ostomy market – the new SenSura® Mio Convex Flip is now available in the United States.

 

All bodies are different, and it is a challenge to create products to fit individual bodies. The SenSura Mio ostomy care portfolio is intended to meet the differing needs of ostomates through its BodyFit Technology®. Flat and convex barriers are common, which the SenSura Mio offers a solution for.

 

SenSura Mio Convex Flip is a new solution for people with an outward body profile and is the first ostomy appliance designed specifically for those that are overweight, obese, or have parastomal bulges or hernias.

 

“With the addition of SenSura® Mio Convex Flip, we continue to build out our ostomy SenSura® Mio portfolio to meet more people’s needs. It is difficult to make a great fit for people with outward body profiles, but the curved, star-shaped barrier can do just that. We are confident that this will make a big difference to our users and give Coloplast a strong competitive edge,” says CEO Kristian Villumsen, Coloplast.

 

Committed to improving outcomes via quality products and life-long patient support

Ostomy care is the 2nd leading cause of 30-day readmission rates in the United States. Coloplast® Care, a comprehensive patient support program, provides patients with individualized support, education, and tools via a patient-focused advisor. The program has been shown to reduce 30-day readmission rates by 30 percent and ER visits by 45 percent.

 

“SenSura® Mio Convex Flip provides a new option for those living with an ostomy. By offering a new innovative product that supports the needs of more users, combined with the Coloplast Care program, we not only impact the quality of life for people living with a stoma – we also make a positive effect on health outcomes,” says Senior Vice President Manu Varma, Chronic Care in North America.

 

Coloplast is the global market leader in ostomy care products, holding 35-40% of the market. Ostomy care products experienced 9% organic growth in 2018, with double-digit growth coming from the United States.

 

Contacts

Lina Danstrup

Senior Media Relations Manager, Corporate Communications

+45 4911 2607

dklina@coloplast.com

Close

Order your free samples

Thank you for your order

Your order is complete!

View desktop version